サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：生物製剤用API製造サービスの世界市場：2023-2033年
市場調査レポート
商品コード
1397897

生物製剤用API製造サービスの世界市場：2023-2033年

Biological Drug API Manufacturing Services Market Report 2023-2033
出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 261 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=198.76円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

生物製剤用API製造サービスの世界市場：2023-2033年
出版日: 2023年12月14日
発行: Visiongain Reports Ltd.
ページ情報: 英文 261 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生物製剤用API製造サービスの市場規模は、2033年にかけてCAGR 11.6%で成長すると予測されています。

さまざまな疾患との闘いにおけるAPIのダイナミックな役割

API (医薬品有効成分) は、癌、心血管疾患、糖尿病、感染症、鎮痛、呼吸器疾患など、さまざまな治療において重要な役割を果たしています。細菌やウイルス感染をターゲットとした医薬品の開発に大きく役立ち、治療ソリューションの進歩に貢献しています。

感染症は世界の死亡原因の主要原因であり、公衆衛生と経済発展に多大な影響を与えています。マラリアや結核などの病気における薬剤耐性株の出現や、殺虫剤耐性菌の出現は、より複雑な医療介入の必要性につながっています。こうした複雑さは、患者にとって経済面と健康面で永続的な影響があります。

これらの病気が世界の健康に及ぼす悪影響や、抗菌薬に対する耐性の高まり、有効な抗生物質のアベイラビリティの縮小といった背景から、革新的企業は、これらの課題に対処できる新しい治療薬の発見・生産への注力を強いられています。

戦略的提携と協力

製薬業界における提携や協力は、生物製剤のAPIを製造するCMOに大きな成長の可能性をもたらします。製薬会社、大学、研究センターとの戦略的提携の構築により、リソースの共有、知識の共有、イノベーションの促進が可能となります。

当レポートでは、世界の生物製剤用API製造サービスの市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主要調査結果
  • 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • SWOT分析
  • 業界分析：PEST分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析

第4章 生物製剤用API製造サービス市場の分析：製造タイプ別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • アウトソーシング
  • 社内製造
    • 市場規模の推移・予測：地域別
    • 市場シェア：地域別

第5章 生物製剤用API製造サービス市場の分析：用途別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • ワクチン
  • mAB
  • インスリン類似体
  • インターフェロン療法
  • ヒト成長ホルモン
  • その他
    • 市場規模の推移・予測：地域別
    • 市場シェア：地域別

第6章 生物製剤用API製造サービス市場の分析：発現プラットフォーム別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 哺乳類細胞培養
  • 微生物発酵
  • その他
    • 市場規模の推移・予測：地域別
    • 市場シェア：地域別

第7章 生物製剤用API製造サービス市場の分析：地域別

  • 主要調査結果
  • 市場規模の推移・予測

第8章 北米の生物製剤用API製造サービス市場の分析

第9章 欧州の生物製剤用API製造サービス市場の分析

第10章 アジア太平洋の生物製剤用API製造サービス市場の分析

第11章 ラテンアメリカの生物製剤用API製造サービス市場の分析

第12章 中東・アフリカの生物製剤用API製造サービス市場の分析

第13章 企業プロファイル

  • AbbVie Inc.
  • Lonza
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Piramal Pharma Solutions
  • Cytovance Biologics
  • FUJIFILM Diosynth Biotechnologies
  • Thermo Fisher Scientific Inc.
  • Samsung Biologics

第14章 総論・推奨事項

  • Visiongainからの総論
  • 市場参入企業への推奨事項
図表

List of Tables

  • Table 1 Biological Drug API Manufacturing Services Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
  • Table 2 Biological Drug API Manufacturing Services Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Biological Drug API Manufacturing Services Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Biological Drug API Manufacturing Services Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Biological Drug API Manufacturing Services Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 7 Outsourced Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 8 In-house Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 9 Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 10 Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 11 mABs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 12 Insulin Analogues Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 13 Interferon Therapies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 14 Human Growth Hormones Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 15 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 16 Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 17 Mammalian Cell Cultures Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 18 Microbial Fermentations Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 19 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 20 Biological Drug API Manufacturing Services Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 21 North America Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 22 North America Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 23 North America Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 24 North America Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 25 U.S. Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 26 Canada Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 27 Europe Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 28 Europe Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 29 Europe Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 30 Europe Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 31 Germany Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 32 UK Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 33 France Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 34 Italy Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 35 Spain Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 36 Russia Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 37 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 38 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 39 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 40 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 41 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 42 Japan Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 43 China Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 44 India Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 45 Australia Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 46 South Korea Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 47 South-East Asia Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 48 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 49 Latin America Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 50 Latin America Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 51 Latin America Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 52 Latin America Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 53 Brazil Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 54 Mexico Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 55 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 56 MEA Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 57 MEA Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 58 MEA Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 59 MEA Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 60 GCC Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 61 South Africa Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 62 Rest of MEA Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 63 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 64 AbbVie, Inc.: Service Benchmarking
  • Table 65 AbbVie, Inc.: Strategic Outlook
  • Table 66 Lonza : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 67 Lonza: Service Benchmarking
  • Table 68 Lonza: Strategic Outlook
  • Table 69 Boehringer Ingelheim International GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 70 Boehringer Ingelheim GmbH: Service Benchmarking
  • Table 71 Boehringer Ingelheim International GmbH: Strategic Outlook
  • Table 72 Catalent, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 73 Catalent, Inc: Service Benchmarking
  • Table 74 Catalent, Inc: Strategic Outlook
  • Table 75 Piramal Pharma Solutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 76 Piramal Pharma Solutions: Service Benchmarking
  • Table 77 Piramal Pharma Solutions: Strategic Outlook
  • Table 78 Cytovance Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 Cytovance Biologics: Service Benchmarking
  • Table 80 Cytovance Biologics: Strategic Outlook
  • Table 81 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 Fujifilm Diosynth Biotechnologies: Service Benchmarking
  • Table 83 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
  • Table 84 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 Thermo Fisher Scientific Inc.: Service Benchmarking
  • Table 86 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 87 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Samsung Biologics: Service Benchmarking
  • Table 89 Samsung Biologics: Strategic Outlook
  •  

List of Figures

  • Figure 1 Biological Drug API Manufacturing Services Market Segmentation
  • Figure 2 Biological Drug API Manufacturing Services Market by Manufacturing Type: Market Attractiveness Index
  • Figure 3 Biological Drug API Manufacturing Services Market by Application: Market Attractiveness Index
  • Figure 4 Biological Drug API Manufacturing Services Market by Expression Platform: Market Attractiveness Index
  • Figure 5 Biological Drug API Manufacturing Services Market Attractiveness Index by Region
  • Figure 6 Biological Drug API Manufacturing Services Market: Market Dynamics
  • Figure 7 SWOT Analysis
  • Figure 8 PEST Analysis
  • Figure 9 Porter's Five Forces Analysis
  • Figure 10 Biological Drug API Manufacturing Services Market by Region, 2023-2033 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 11 Biological Drug API Manufacturing Services Market by Region, 2023-2033 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 12 Biological Drug API Manufacturing Services Market by Region, 2023-2033 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 13 Biological Drug API Manufacturing Services Market by Region, 2023-2033 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 14 Biological Drug API Manufacturing Services Market Attractiveness Index by Manufacturing Type
  • Figure 15 Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR %)
  • Figure 16 Biological Drug API Manufacturing Services Market Share Forecast by Manufacturing Type, 2023, 2028, 2033 (%)
  • Figure 17 Outsourced Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 18 Outsourced Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 19 In-house Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 20 In-house Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 21 Biological Drug API Manufacturing Services Market Attractiveness Index by Manufacturing Type
  • Figure 22 Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 23 Biological Drug API Manufacturing Services Market Share Forecast by Application, 2023, 2028, 2033 (%)
  • Figure 24 Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 25 Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 26 mABs Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 27 mABs Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 28 Insulin Analogues Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 29 Insulin Analogues Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 30 Interferon Therapies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 31 Interferon Therapies Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 32 Human Growth Hormones Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 33 Human Growth Hormones Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 34 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 35 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 36 Biological Drug API Manufacturing Services Market Attractiveness Index by Expression Platform
  • Figure 37 Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR %)
  • Figure 38 Biological Drug API Manufacturing Services Market Share Forecast by Expression Platform, 2023, 2028, 2033 (%)
  • Figure 39 Mammalian Cell Cultures Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 40 Mammalian Cell Cultures Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 41 Microbial Fermentations Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 42 Microbial Fermentations Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 43 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 44 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 45 Biological Drug API Manufacturing Services Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
  • Figure 46 Biological Drug API Manufacturing Services Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 47 Biological Drug API Manufacturing Services Market by Region, 2023-2033 (US$ Mn)
  • Figure 48 North America Biological Drug API Manufacturing Services Market Attractiveness Index
  • Figure 49 North America Biological Drug API Manufacturing Services Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 50 North America Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 51 North America Biological Drug API Manufacturing Services Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 52 North America Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR %)
  • Figure 53 North America Biological Drug API Manufacturing Services Market Share Forecast by Manufacturing Type, 2023 & 2033 (%)
  • Figure 54 North America Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 55 North America Biological Drug API Manufacturing Services Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 56 North America Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR %)
  • Figure 57 North America Biological Drug API Manufacturing Services Market Share Forecast by Expression Platform, 2023 & 2033 (%)
  • Figure 58 U.S. Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 59 Canada Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 60 Europe Biological Drug API Manufacturing Services Market Attractiveness Index
  • Figure 61 Europe Biological Drug API Manufacturing Services Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 62 Europe Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 63 Europe Biological Drug API Manufacturing Services Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 64 Europe Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR %)
  • Figure 65 Europe Biological Drug API Manufacturing Services Market Share Forecast by Manufacturing Type, 2023 & 2033 (%)
  • Figure 66 Europe Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 67 Europe Biological Drug API Manufacturing Services Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 68 Europe Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR %)
  • Figure 69 Europe Biological Drug API Manufacturing Services Market Share Forecast by Expression Platform, 2023 & 2033 (%)
  • Figure 70 Germany Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 71 UK Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 72 France Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 73 Italy Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 74 Spain Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 75 Russia Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 76 Rest of Europe Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 77 Asia Pacific Biological Drug API Manufacturing Services Market Attractiveness Index
  • Figure 78 Asia Pacific Biological Drug API Manufacturing Services Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 79 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 80 Asia Pacific Biological Drug API Manufacturing Services Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 81 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR %)
  • Figure 82 Asia Pacific Biological Drug API Manufacturing Services Market Share Forecast by Manufacturing Type, 2023 & 2033 (%)
  • Figure 83 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 84 Asia Pacific Biological Drug API Manufacturing Services Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 85 Asia Pacific Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR %)
  • Figure 86 Asia Pacific Biological Drug API Manufacturing Services Market Share Forecast by Expression Platform, 2023 & 2033 (%)
  • Figure 87 Japan Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 88 China Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 89 India Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 90 Australia Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 91 South Korea Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 92 South East Asia Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 93 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 94 Latin America Biological Drug API Manufacturing Services Market Attractiveness Index
  • Figure 95 Latin America Biological Drug API Manufacturing Services Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 96 Latin America Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 97 Latin America Biological Drug API Manufacturing Services Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 98 Latin America Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR %)
  • Figure 99 Latin America Biological Drug API Manufacturing Services Market Share Forecast by Manufacturing Type, 2023 & 2033 (%)
  • Figure 100 Latin America Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 101 Latin America Biological Drug API Manufacturing Services Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 102 Latin America Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR %)
  • Figure 103 Latin America Biological Drug API Manufacturing Services Market Share Forecast by Expression Platform, 2023 & 2033 (%)
  • Figure 104 Brazil Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 105 Mexico Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 106 Rest of Latin America Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 107 MEA Biological Drug API Manufacturing Services Market Attractiveness Index
  • Figure 108 MEA Biological Drug API Manufacturing Services Market by Region, 2023, 2028 & 2033 (US$ million)
  • Figure 109 MEA Biological Drug API Manufacturing Services Market Forecast by Country, 2023-2033 (US$ million)
  • Figure 110 MEA Biological Drug API Manufacturing Services Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 111 MEA Biological Drug API Manufacturing Services Market Forecast by Manufacturing Type, 2023-2033 (US$ Million, AGR %)
  • Figure 112 MEA Biological Drug API Manufacturing Services Market Share Forecast by Manufacturing Type, 2023 & 2033 (%)
  • Figure 113 MEA Biological Drug API Manufacturing Services Market Forecast by Application, 2023-2033 (US$ Million, AGR %)
  • Figure 114 MEA Biological Drug API Manufacturing Services Market Share Forecast by Application, 2023 & 2033 (%)
  • Figure 115 MEA Biological Drug API Manufacturing Services Market Forecast by Expression Platform, 2023-2033 (US$ Million, AGR %)
  • Figure 116 MEA Biological Drug API Manufacturing Services Market Share Forecast by Expression Platform, 2023 & 2033 (%)
  • Figure 117 GCC Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 118 South Africa Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 119 Rest of MEA Biological Drug API Manufacturing Services Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 120 AbbVie Inc.: Net Revenue, 2015-2022 (US$ Million, AGR %)
  • Figure 121 AbbVie Inc.: Regional Market Shares (%), 2022
  • Figure 122 AbbVie Inc.: R&D, 2015-2022 (US$ Million, AGR %)
  • Figure 123 Lonza : Net Revenue, 2015-2022 (US$ Million, AGR %)
  • Figure 124 Lonza : R&D, 2017-2021 (US$ Million, AGR %)
  • Figure 125 Lonza : Segment Market Shares, 2022
  • Figure 126 Lonza : Regional Market Shares, 2022
  • Figure 127 Boehringer Ingelheim International GmbH: Net Revenue, 2015-2022 (US$ Million, AGR %)
  • Figure 128 Boehringer Ingelheim International GmbH: Segment Market Shares, 2022
  • Figure 129 Boehringer Ingelheim International GmbH: Regional Market Shares, 2022
  • Figure 130 Catalent, Inc. : Net Revenue, 2015-2022 (US$ Million, AGR (%)
  • Figure 131 Catalent, Inc. : Segment Market Shares, 2022
  • Figure 132 Catalent, Inc. : Regional Market Shares, 2022
  • Figure 133 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2022 (US$ million, AGR%)
  • Figure 134 Thermo Fisher Scientific Inc.: R&D, 2015-2022 (US$ million, AGR%)
  • Figure 135 Thermo Fisher Scientific Inc.: Regional Market Shares, 2022 (%)
目次
Product Code: PHA1297

The global Biological Drug API Manufacturing Services market is projected to grow at a CAGR of 11.6% by 2033.

“The Biological Drug API Manufacturing Services Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Dynamic Role of APIs in Combatting Various Diseases

APIs (Active Pharmaceutical Ingredients) play a crucial role in various medical treatments, including cancer, cardiovascular disease, diabetes, infectious diseases, pain relief, and respiratory conditions. They significantly aid in the development of medications targeting bacterial and viral infections, contributing to advancements in therapeutic solutions.

Infectious diseases, a leading cause of global mortality, profoundly impact public health and economic progress. The emergence of drug-resistant strains in diseases like malaria and tuberculosis, along with insecticide-resistant organisms, has led to the necessity for more intricate medical interventions. These complexities have enduring financial and health implications for patients.

Given the adverse effects of these illnesses on worldwide health, the escalating resistance to antimicrobials, and the diminishing availability of effective antibiotics, innovative businesses are compelled to focus on discovering and producing new therapeutic medications to address these challenges.

Strategic Partnerships and Collaborations

Partnerships and collaborations within the pharmaceutical industry offer CMOs producing biological drug APIs substantial growth prospects. Creating strategic partnerships with pharmaceutical companies, universities, and research centres can encourage resource sharing, knowledge sharing, and innovation.

CMOs can help partners accelerate their drug development timelines by bringing their process development, optimisation, and scale-up expertise to early-stage collaborations. In addition, access to proprietary platforms, cutting-edge technologies, and intellectual property is made possible through strategic partnerships, which improve the CMO's capabilities and broaden its range of services.

Additionally, by forming consortia or alliances with several pharmaceutical companies, CMOs can broaden their clientele, become less reliant on a single partner, and build a network for collaborative research and development. In the field of biological drug manufacturing, collaborative approaches enable the sharing of resources, knowledge, and risk in a way that benefits both parties and promotes innovation and expansion.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the biological drug API manufacturing services market evolving?
  • What is driving and restraining the biological drug API manufacturing services market?
  • How will each biological drug API manufacturing services submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each biological drug API manufacturing services submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading biological drug API manufacturing services markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the biological drug API manufacturing services projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of

biological drug API manufacturing services projects taking place now and over the next 10 years?

  • Is there a greater need for product commercialisation to further scale the biological drug API manufacturing services market?
  • Where is the biological drug API manufacturing services market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biological drug API manufacturing services market today, and over the next 10 years:

  • Our 261-page report provides 89 tables, 135 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the biological drug API manufacturing services market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Manufacturing Type

  • Outsourced
  • In-house

Application

  • Vaccines
  • mABs
  • Insulin Analogues
  • Interferon Therapies
  • Human Growth Hormones
  • Others

Expression Platform

  • Mammalian Cell Cultures
  • Microbial Fermentations
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Biological Drug API Manufacturing Services Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies profiled in the report:

  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Cytovance Biologics
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Piramal Pharma Solutions
  • Samsung Biologics
  • Thermo Fisher Scientific Inc.

Overall world revenue for Biological Drug API Manufacturing Services Market, 2023 to 2033 in terms of value the market will surpass US$8,000 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the “Biological Drug API Manufacturing Services Market, 2023 to 2033” report help you?

In summary, our 260+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Biological Drug API Manufacturing Services Market 2023 to 2033, with forecasts for manufacturing type, application and expression platform, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 22 key national markets - See forecasts for the Biological Drug API Manufacturing Services Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Biological Drug API Manufacturing Services Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Biological Drug API Manufacturing Services Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Biological Drug API Manufacturing Services Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Market Driving Factors
    • 3.3.1 Biological Patent Expirations to Fuel Market Growth
    • 3.3.2 Outsourcing as a Driver for Market Growth
    • 3.3.3 Growing Investments in Orphan Drugs
    • 3.3.4 Single Use Technology will Become Essential Over the Next Decade
  • 3.4 Market Restraining Factors
    • 3.4.1 Manufacturing APIs for Biologics to Restrain Market Growth
    • 3.4.2 Pricing Pressure to Impede Market Growth
    • 3.4.3 Regulatory Scenarios to Restrain Market Growth
    • 3.4.4 Excessive Production is Projected to Impede Market Growth
    • 3.4.5 API Production is a Challenging Task
  • 3.5 Market Opportunities
    • 3.5.1 Advancements in Bioprocessing Techniques
    • 3.5.2 Customisation and Flexibility in Manufacturing
    • 3.5.3 Strategic Partnerships and Collaborations
    • 3.5.4 Emerging Economies to Offer Lucrative Growth Opportunities
  • 3.6 SWOT Analysis
    • 3.6.1 Strengths
    • 3.6.2 Weaknesses
    • 3.6.3 Opportunities
    • 3.6.4 Threats
  • 3.7 Industry analysis - PEST Analysis
    • 3.7.1 Political
    • 3.7.2 Economical
    • 3.7.3 Social
    • 3.7.4 Technological
  • 3.8 Porter's Five Forces Analysis
    • 3.8.1 Bargaining Power of Suppliers is Low
    • 3.8.2 Bargaining Power of Buyers is Medium
    • 3.8.3 Competitive Rivalry is High Due to Presence of Established Firms
    • 3.8.4 Threat of Substitutes is Medium
    • 3.8.5 Threat of New Entrants is Low Owing to Huge Associated Costs
  • 3.9 COVID-19 Impact Analysis

4 Biological Drug API Manufacturing Services Market Analysis by Manufacturing Type

  • 4.1 Key Findings
  • 4.2 Manufacturing Type Segment: Market Attractiveness Index
  • 4.3 Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
  • 4.4 Outsourced
    • 4.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 In-house
    • 4.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Biological Drug API Manufacturing Services Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
  • 5.4 Vaccines
    • 5.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 mABs
    • 5.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Insulin Analogues
    • 5.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)
  • 5.7 Interferon Therapies
    • 5.7.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 5.7.2 Market Share by Region, 2023 & 2033 (%)
  • 5.8 Human Growth Hormones
    • 5.8.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 5.8.2 Market Share by Region, 2023 & 2033 (%)
  • 5.9 Others
    • 5.9.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 5.9.2 Market Share by Region, 2023 & 2033 (%)

6 Biological Drug API Manufacturing Services Market Analysis by Expression Platform

  • 6.1 Key Findings
  • 6.2 Expression Platform Segment: Market Attractiveness Index
  • 6.3 Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
  • 6.4 Mammalian Cell Cultures
    • 6.4.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Microbial Fermentations
    • 6.5.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Others
    • 6.6.1 Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)

7 Biological Drug API Manufacturing Services Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Biological Drug API Manufacturing Services Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Biological Drug API Manufacturing Services Market Attractiveness Index
  • 8.3 North America Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 8.4 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
  • 8.5 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
  • 8.6 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
  • 8.7 North America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
  • 8.8 U.S. Biological Drug API Manufacturing Services Market Analysis
  • 8.9 Canada Biological Drug API Manufacturing Services Market Analysis

9 Europe Biological Drug API Manufacturing Services Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Biological Drug API Manufacturing Services Market Attractiveness Index
  • 9.3 Europe Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 9.4 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
  • 9.5 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
  • 9.6 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
  • 9.7 Europe Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
  • 9.8 Germany Biological Drug API Manufacturing Services Market Analysis
  • 9.9 UK Biological Drug API Manufacturing Services Market Analysis
  • 9.10 France Biological Drug API Manufacturing Services Market Analysis
  • 9.11 Italy Biological Drug API Manufacturing Services Market Analysis
  • 9.12 Spain Biological Drug API Manufacturing Services Market Analysis
  • 9.13 Russia Biological Drug API Manufacturing Services Market Analysis
  • 9.14 Rest of Europe Biological Drug API Manufacturing Services Market Analysis

10 Asia Pacific Biological Drug API Manufacturing Services Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Biological Drug API Manufacturing Services Market Attractiveness Index
  • 10.3 Asia Pacific Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 10.4 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
  • 10.5 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
  • 10.6 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
  • 10.7 Asia Pacific Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
  • 10.8 Japan Biological Drug API Manufacturing Services Market Analysis
  • 10.9 China Biological Drug API Manufacturing Services Market Analysis
  • 10.10 India Biological Drug API Manufacturing Services Market Analysis
  • 10.11 Australia Biological Drug API Manufacturing Services Market Analysis
  • 10.12 South Korea Biological Drug API Manufacturing Services Market Analysis
  • 10.13 South East Asia Biological Drug API Manufacturing Services Market Analysis
  • 10.14 Rest of Asia Pacific Biological Drug API Manufacturing Services Market Analysis

11 Latin America Biological Drug API Manufacturing Services Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Biological Drug API Manufacturing Services Market Attractiveness Index
  • 11.3 Latin America Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 11.4 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
  • 11.5 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
  • 11.6 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
  • 11.7 Latin America Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
  • 11.8 Brazil Biological Drug API Manufacturing Services Market Analysis
  • 11.9 Mexico Biological Drug API Manufacturing Services Market Analysis
  • 11.10 Rest of Latin America Biological Drug API Manufacturing Services Market Analysis

12 MEA Biological Drug API Manufacturing Services Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Biological Drug API Manufacturing Services Market Attractiveness Index
  • 12.3 MEA Biological Drug API Manufacturing Services Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 12.4 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Country
  • 12.5 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Manufacturing Type
  • 12.6 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Application
  • 12.7 MEA Biological Drug API Manufacturing Services Market Size Estimation and Forecast by Expression Platform
  • 12.8 GCC Biological Drug API Manufacturing Services Market Analysis
  • 12.9 South Africa Biological Drug API Manufacturing Services Market Analysis
  • 12.10 Rest of MEA Biological Drug API Manufacturing Services Market Analysis

13 Company Profiles

  • 13.1 AbbVie Inc.
    • 13.1.1 Company Snapshot
    • 13.1.2 Company Overview
    • 13.1.3 Financial Analysis
    • 13.1.4 Service Benchmarking
    • 13.1.5 Strategic Outlook
  • 13.2 Lonza
    • 13.2.1 Company Snapshot
    • 13.2.2 Company Overview
    • 13.2.3 Financial Analysis
    • 13.2.4 Service Benchmarking
    • 13.2.5 Strategic Outlook
  • 13.3 Boehringer Ingelheim International GmbH
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
    • 13.3.4 Service Benchmarking
    • 13.3.5 Strategic Outlook
  • 13.4 Catalent, Inc.
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
    • 13.4.4 Service Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 Piramal Pharma Solutions
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Service Benchmarking
    • 13.5.4 Strategic Outlook
  • 13.6 Cytovance Biologics
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Service Benchmarking
    • 13.6.4 Strategic Outlook
  • 13.7 FUJIFILM Diosynth Biotechnologies
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Service Benchmarking
    • 13.7.4 Strategic Outlook
  • 13.8 Thermo Fisher Scientific Inc.
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis
    • 13.8.4 Service Benchmarking
    • 13.8.5 Strategic Outlook
  • 13.9 Samsung Biologics
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Service Benchmarking
    • 13.9.4 Strategic Outlook

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from Visiongain
  • 14.2 Recommendations for Market Players